Currently, a number of new cytokine biomarkers, such as EGF, sCD40L, and VEGF [11] or TNF-α, IL-12 p40, and IL-17 [12] are credited to be promising candidates for the immunodiagnostic of active TB or LTBI. This evidence concerns the gene VEGFA and tuberculosis.